Valuation: Implantica AG

Market Cap 1.36B 1.57B 1.27B 1.16B 2.18B 149B 2.21B 14.96B 5.85B 74.83B 5.88B 5.76B 250B P/E 2026 *
-15x
P/E 2027 * -13x
Enterprise Value 1.33B 1.54B 1.25B 1.14B 2.14B 147B 2.17B 14.67B 5.73B 73.36B 5.77B 5.64B 245B EV / Sales 2026 *
373x
EV / Sales 2027 * 148x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
1 day-2.40%
1 week-11.26%
Current month-14.56%
1 month-20.00%
3 months+25.71%
6 months+13.67%
Current year+5.39%
1 week 50.8
Extreme 50.8
60.1
1 month 50.8
Extreme 50.8
65.3
Current year 38
Extreme 38
69
1 year 38
Extreme 38
82
3 years 16
Extreme 16
86.4
5 years 15.4
Extreme 15.4
136.8
10 years 15.4
Extreme 15.4
178.9
Manager TitleAgeSince
Chief Executive Officer 72 2014-12-31
Director of Finance/CFO 48 2019-12-31
Corporate Officer/Principal 69 -
Director TitleAgeSince
Chairman 67 2019-12-31
Director/Board Member 62 2019-12-31
Director/Board Member 71 2019-12-31
Date Insider Type Main position Quantity % Market Cap.
9/24/25 Sell

Chief Financial Officer

16,700 0.0287%
9/24/25 Sell

Chief Financial Officer

17,100 0.0294%
9/24/25 Sell

Chief Financial Officer

29,500 0.0508%
Change 5-day change 1-year change 3-year change Capi.($)
-2.40%-11.26%-24.68%+123.26% 1.61B
+0.09%+1.04%+31.39%+31.98% 12.85B
+0.13%+0.38%+19.80%+27.05% 6.84B
-0.87%+5.85%+53.33%+37.30% 6.49B
+4.65%+11.53% - - 5.56B
-0.81%+0.48%-27.58%+49.71% 4.56B
+0.52%-2.10%-24.48%-18.36% 3.97B
-0.40%+9.60%+55.11%-43.69% 2.06B
+1.36%+7.19%+63.02%-4.14% 1.71B
+1.48%+3.58%-29.90%-41.80% 1.31B
Average +0.36%+3.56%+12.89%+17.92% 4.7B
Weighted average by Cap. +0.41%+3.64%+19.43%+25.09%

Financials

2026 *2027 *
Net sales 3.57M 4.12M 3.34M 3.05M 5.73M 393M 5.82M 39.34M 15.38M 197M 15.47M 15.13M 656M 9.14M 10.56M 8.57M 7.82M 14.69M 1.01B 14.92M 101M 39.39M 504M 39.63M 38.77M 1.68B
Net income -22.17M -25.59M -20.77M -18.94M -35.62M -2.44B -36.16M -244M -95.49M -1.22B -96.06M -93.98M -4.07B -25.65M -29.61M -24.04M -21.92M -41.22M -2.82B -41.85M -283M -111M -1.41B -111M -109M -4.72B
Net Debt -26.74M -30.86M -25.05M -22.85M -42.96M -2.94B -43.62M -295M -115M -1.47B -116M -113M -4.92B -308K -356K -289K -263K -495K -33.93M -503K -3.4M -1.33M -16.99M -1.34M -1.31M -56.64M
Logo Implantica AG
Implantica AG is Lichtenstein-based medical technology Company, whose mission is to provide effective treatment for serious health conditions and to improve patients' life through the use of advanced technologies in the human body, ultimately aiming to reduce costs and increase efficiency in the healthcare System. The therapies developed by Implantica are based on implants that are inserted into the patient's body and remain in the body permanently or semi-permanently to replace bodily functions and/or treat diseases. The Company focuses on the discovery, development and prospective commercialization of medical products and implants that are intended for use in different treatment fields like in the area of gastrointestinal surgery and urology. The Company's lead product is RefluxStop, a passive, implant to prevent gastroesophageal reflux disease (GERD).
Employees
-
Date Price Change Volume
26-08-12 SEK 52.80 -2.40% 41,475
26-08-11 SEK 54.10 -6.72% 128,402
26-08-10 SEK 58.00 -1.02% 48,125
26-08-07 SEK 58.60 -0.51% 16,909
26-08-06 SEK 58.90 -1.01% 27,300
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
4.791EUR
Average target price
6.725EUR
Spread / Average Target
+40.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IMP A SDB Stock